Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Metastatic Adenocarcinoma of the Pancreas”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT00005860
What this trial is testing

Oxaliplatin With Or Without Floxuridine and Leucovorin in Treating Patients With Metastatic Cancer of the Peritoneum

Who this might be right for
Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT07488676
What this trial is testing

ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

Who this might be right for
Gastric or Gastro-esophageal Junction (GEJ) AdenocarcinomaPancreatic Adenocarcinoma
Astellas Pharma Global Development, Inc. 150
Not applicableEnded earlyNCT06341725
What this trial is testing

EUS Role in Non-metastatic Pancreatic Adenocarcinoma Lymph Nodes Staging

Who this might be right for
Pancreatic AdenocarcinomaLymph Node Metastasis
Paolo Giorgio Arcidiacono, MD 2
Testing effectiveness (Phase 2)Ended earlyNCT03376659
What this trial is testing

Durvalumab Plus CV301 With Maintenance Chemotherapy in Metastatic Colorectal or Pancreatic Adenocarcinoma

Who this might be right for
Metastatic Colorectal CancerColorectal AdenocarcinomaPancreatic Adenocarcinoma+1 more
Georgetown University 8
Testing effectiveness (Phase 2)Study completedNCT01693523
What this trial is testing

Minocycline Study in Pancreatic Cancer Patients

Who this might be right for
Pancreatic Cancer
M.D. Anderson Cancer Center 80
Testing effectiveness (Phase 2)Looking for participantsNCT06261359
What this trial is testing

CEND-1 With Chemotherapy as First-Line Therapy in Patients With Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma (PDAC)
Qilu Pharmaceutical Co., Ltd. 120
Testing effectiveness (Phase 2)Study completedNCT01806675
What this trial is testing

18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy

Who this might be right for
Adult Giant Cell GlioblastomaAdult GlioblastomaAdult Gliosarcoma+41 more
Sanjiv Sam Gambhir 25
Testing effectiveness (Phase 2)Study completedNCT04662112
What this trial is testing

Liposomal Irinotecan, S-1, and Oxaliplatin in Advanced Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic CancerPancreatic Ductal Adenocarcinoma
Asan Medical Center 40
Very early researchStudy completedNCT02847000
What this trial is testing

P53/p16-Independent Epigenetic Therapy With Oral Decitabine/Tetrahydrouridine for Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic Adenocarcinoma
Yogen Saunthararajah 13
Testing effectiveness (Phase 2)Study completedNCT00102700
What this trial is testing

ARQ 501 in Combination With Gemcitabine in Subjects With Pancreatic Cancer

Who this might be right for
Pancreatic CancerAdenocarcinoma
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) 66
Testing effectiveness (Phase 2)Looking for participantsNCT06747845
What this trial is testing

Maintenance Niraparib Plus Ipilimumab in Patients With Metastatic Pancreatic Adenocarcinoma Whose Disease Has Not Progressed on Platinum-Based Chemotherapy

Who this might be right for
Pancreatic Adenocarcinoma Metastatic
Abramson Cancer Center at Penn Medicine 68
Testing effectiveness (Phase 2)Study completedNCT00003677
What this trial is testing

Dolastatin 10 in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
M.D. Anderson Cancer Center 9
Early research (Phase 1)Looking for participantsNCT07377045
What this trial is testing

Clinical Trial of OMTX705 in Combination With Gemcitabine/Nab-Paclitaxel and Tislelizumab in Patients With Advanced/Metastatic Pancreatic Adenocarcinoma

Who this might be right for
Pancreatic Adenocarcinoma Metastatic
Oncomatryx Biopharma S.L. 69
Large-scale testing (Phase 3)Looking for participantsNCT06861088
What this trial is testing

The Effect of Kinisoquin™ on Thromboembolic Events in Patients With Metastatic or Locally Advanced Pancreatic Cancer

Who this might be right for
Venous ThromboembolismMetastatic Pancreatic CancerLocally Advanced Pancreatic Adenocarcinoma
Quercis Pharma AG 480
Early research (Phase 1)Study completedNCT02166255
What this trial is testing

APN401 in Treating Patients With Melanoma, Kidney Cancer, Pancreatic Cancer, or Other Solid Tumors That Are Metastatic or Cannot Be Removed By Surgery

Who this might be right for
Recurrent MelanomaRecurrent Pancreatic CancerRecurrent Renal Cell Cancer+9 more
Wake Forest University Health Sciences 17
Testing effectiveness (Phase 2)Study completedNCT00377936
What this trial is testing

EndoTAG-1 / Gemcitabine Combination Therapy to Treat Locally Advanced and/or Metastatic Adenocarcinoma of the Pancreas

Who this might be right for
AdenocarcinomaMetastasisPancreas Neoplasms
MediGene 212
Testing effectiveness (Phase 2)Study completedNCT02907099
What this trial is testing

Pembrolizumab and CXCR4 Antagonist BL-8040 in Treating Patients With Metastatic Pancreatic Cancer

Who this might be right for
Metastatic Pancreatic AdenocarcinomaRecurrent Pancreatic AdenocarcinomaStage IV Pancreatic Cancer AJCC v6 and v7
M.D. Anderson Cancer Center 20
Testing effectiveness (Phase 2)Active Not RecruitingNCT05933265
What this trial is testing

Study of LP-184 in Patients With Advanced Solid Tumors

Who this might be right for
Advanced Solid TumorMetastatic Solid TumorGBM+4 more
Lantern Pharma Inc. 64
Testing effectiveness (Phase 2)Active Not RecruitingNCT04666740
What this trial is testing

Pembrolizumab and Olaparib for People With Metastatic Pancreatic Ductal Adenocarcinoma and Homologous Recombination Deficiency or Exceptional Treatment Response to Platinum-Based Therapy

Who this might be right for
Metastatic Pancreatic Ductal AdenocarcinomaHomologous Recombination Deficiency (HRD)
Memorial Sloan Kettering Cancer Center 63
Large-scale testing (Phase 3)Study completedNCT01231347
What this trial is testing

QUILT-2.014: Gemcitabine and AMG 479 in Metastatic Adenocarcinoma of the Pancreas

Who this might be right for
Adenocarcinoma of the PancreasAdvanced Solid TumorsCancer+13 more
NantCell, Inc. 800
Next Page